New vaccines for cancer and flu are among a host of promising RNA therapeutics currently in human clinical trials.

In the era of AI-generated news, readers value trust over customised content
The future of AI in journalism will depend on a balance between benefits and risk, and raising audience comfort, trust and news literacy.

